Inovio Pharmaceuticals, Inc.
NASDAQ: INO
$1.84
-$0.15 (-7.5%)
Closing price May 18, 2022
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex Pharmaceuticals and Voya Financial.
3 years ago
Last Updated: 2 years ago
We screened our 24/7 Wall St. research database and found five stocks trading under the $5 level that could prove exciting additions to portfolios looking for solid alpha potential.
3 years ago
Last Updated: 2 years ago
We screened our 24/7 Wall St. research database and found five biotech stocks trading under the $10 level that could provide investors with some solid upside potential.
3 years ago
Last Updated: 2 years ago
Inovio Pharmaceuticals shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused by human...
4 years ago
Last Updated: 2 years ago
Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika virus study.
4 years ago
Last Updated: 2 years ago
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
4 years ago
Last Updated: 2 years ago
Shares of Inovio Pharmaceuticals saw a massive gain early on Wednesday after the company announced a critical update from its HIV vaccine.
4 years ago
Last Updated: 2 years ago
Inovio Pharmaceuticals shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial.
5 years ago
Last Updated: 2 years ago
Shares of Inovio Pharmaceuticals slid in Monday’s session on news that the FDA placed a clinical hold on a proposed Inovio Phase 3 clinical program.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Ford, General Motors, Hecla Mining, Vale and Waste Management.
5 years ago
Last Updated: 2 years ago
Inovio Pharmaceuticals has announced that it received approval to initiate a Phase 1 human trial to evaluate its Zika DNA vaccine (GLS-5700) to prevent infection from the Zika virus.
5 years ago
Last Updated: 2 years ago
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable companies targeting...
5 years ago
Last Updated: 2 years ago
Regular 24/7 Wall St. readers know that earnings season typically slows the rate of insider activity in a big way. Corporations go into what is called the silent period, before, during and sometimes...
6 years ago
Last Updated: 2 years ago
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
6 years ago
Last Updated: 2 years ago
Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.
6 years ago
Last Updated: 2 years ago